Irja Davidkin

Summary

Publications

  1. ncbi MMR vaccination and disease elimination: the Finnish experience
    Irja Davidkin
    National Institute for Health and Welfare, Department of Vaccination and Immune Protection, Helsinki, Finland
    Expert Rev Vaccines 9:1045-53. 2010
  2. ncbi Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up
    Irja Davidkin
    National Public Health Institute, University of Helsinki, Helsinki, Finland
    J Infect Dis 197:950-6. 2008
  3. ncbi Epidemiology of hepatitis A in Finland in 1990-2007
    Mia Broman
    National Institute for Health and Welfare, Helsinki, Finland
    J Med Virol 82:934-41. 2010
  4. ncbi Waning Antibody Levels and Avidity: Implications for MMR Vaccine-Induced Protection
    Mia Kontio
    Department of Infectious Disease Surveillance and Control, National Institute for Health and Welfare, Helsinki
    J Infect Dis 206:1542-8. 2012
  5. ncbi Measles, mumps, and rubella in Finland: 25 years of a nationwide elimination programme
    Heikki Peltola
    Helsinki University Central Hospital, Hospital for Children and Adolescents, Helsinki, Finland
    Lancet Infect Dis 8:796-803. 2008
  6. ncbi Cellular immunity to mumps virus in young adults 21 years after measles-mumps-rubella vaccination
    Sari Jokinen
    Department of Viral Diseases and Immunology, National Public Health Institute, Helsinki, Finland
    J Infect Dis 196:861-7. 2007
  7. ncbi Immunity after (re)vaccination of paediatric patients following haematopoietic stem cell transplantation
    Helena Olkinuora
    Division of Hematology Oncology and Stem Cell Transplantation, Children s Hospital, Helsinki University Central Hospital, Helsinki, Finland
    Acta Paediatr 101:e373-7. 2012
  8. ncbi Etiology of mumps-like illnesses in children and adolescents vaccinated for measles, mumps, and rubella
    Irja Davidkin
    National Public Health Institute, Helsinki, Finland
    J Infect Dis 191:719-23. 2005
  9. ncbi Molecular epidemiology of hepatitis A in St. Petersburg, Russia, 1997-2003
    Irja Davidkin
    National Public Health Institute, Helsinki, Finland
    J Med Virol 79:657-62. 2007

Collaborators

Detail Information

Publications9

  1. ncbi MMR vaccination and disease elimination: the Finnish experience
    Irja Davidkin
    National Institute for Health and Welfare, Department of Vaccination and Immune Protection, Helsinki, Finland
    Expert Rev Vaccines 9:1045-53. 2010
    ..Here we present an overview of MMR vaccinations and the Finnish experience of the MMR disease elimination process, and we describe surveillance activities in the era following elimination in Finland...
  2. ncbi Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up
    Irja Davidkin
    National Public Health Institute, University of Helsinki, Helsinki, Finland
    J Infect Dis 197:950-6. 2008
    ..The persistence of antibodies against measles, mumps, and rubella induced by the measles-mumps-rubella (MMR) vaccine and the kinetics of antibody decline after the second MMR vaccine dose were studied in the same cohort for 20 years...
  3. ncbi Epidemiology of hepatitis A in Finland in 1990-2007
    Mia Broman
    National Institute for Health and Welfare, Helsinki, Finland
    J Med Virol 82:934-41. 2010
    ..The low seroprevalence, especially in younger age groups, makes the population vulnerable to infection, which can be compensated for by increasing the number of vaccinations...
  4. ncbi Waning Antibody Levels and Avidity: Implications for MMR Vaccine-Induced Protection
    Mia Kontio
    Department of Infectious Disease Surveillance and Control, National Institute for Health and Welfare, Helsinki
    J Infect Dis 206:1542-8. 2012
    ..Waning of both the concentration as well as the avidity of antibodies might contribute to measles and mumps infections in twice-MMR-vaccinated individuals...
  5. ncbi Measles, mumps, and rubella in Finland: 25 years of a nationwide elimination programme
    Heikki Peltola
    Helsinki University Central Hospital, Hospital for Children and Adolescents, Helsinki, Finland
    Lancet Infect Dis 8:796-803. 2008
    ..To maintain the absence of these diseases, the adopted policy should continue, but the country should also be prepared for prompt supplementary vaccinations in the case of epidemic outbreaks...
  6. ncbi Cellular immunity to mumps virus in young adults 21 years after measles-mumps-rubella vaccination
    Sari Jokinen
    Department of Viral Diseases and Immunology, National Public Health Institute, Helsinki, Finland
    J Infect Dis 196:861-7. 2007
    ..However, the persistence of MMR vaccine-induced immunity in the absence of endemic infection has remained unknown...
  7. ncbi Immunity after (re)vaccination of paediatric patients following haematopoietic stem cell transplantation
    Helena Olkinuora
    Division of Hematology Oncology and Stem Cell Transplantation, Children s Hospital, Helsinki University Central Hospital, Helsinki, Finland
    Acta Paediatr 101:e373-7. 2012
    ..Loss of specific immunity follows allogeneic haematopoietic stem cell transplantation (HSCT) in the majority of cases. Responses to (re)vaccinations can be used as indicators of a functional immunological recovery...
  8. ncbi Etiology of mumps-like illnesses in children and adolescents vaccinated for measles, mumps, and rubella
    Irja Davidkin
    National Public Health Institute, Helsinki, Finland
    J Infect Dis 191:719-23. 2005
    ....
  9. ncbi Molecular epidemiology of hepatitis A in St. Petersburg, Russia, 1997-2003
    Irja Davidkin
    National Public Health Institute, Helsinki, Finland
    J Med Virol 79:657-62. 2007
    ..The results indicate the usefulness of molecular epidemiological methods in studying changes in the circulating HAV strains and in tracing transmission routes...